Acute Promyelocytic Leukemia Unknown Status Phase 2 Trials for IRX-5183 (DB05653)

Back to Acute Promyelocytic Leukemia

Also known as: Leukaemia (Acute Promyelocytic) / Promyelocytic Leukemia, Acute / Leukemia, Promyelocytic, Acute / Acute Promyelocytic Leukemia (APL) / Acute promyelocytic leukaemia / Acute promyelocytic leukemia with failed remission / Disorder: Acute promyelocytic leukemia, FAB M3 (disorder) / Acute promyelocytic leukemia (morphologic abnormality) / AML M3

IndicationStatusPhase
DBCOND0036178 (Acute Promyelocytic Leukemia)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00675870Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic LeukemiaTreatment